Comparison studies on potency tests for rabies vaccines
Wiktor, T.J.; Atanasiu, P.; Bahmanyar, M.; Boegel, K.; Cox, J.H.; Diaz, A.M.; Fitzgerald, E.A.; Kuwert, E.; Netter, R.; Selimov, M.; Turner, G.; van Steenis, G.
Developments in Biological Standardization 40: 171-178
1978
ISSN/ISBN: 0301-5149 PMID: 355011 Document Number: 125464
Eleven laboratories from eight countries and four continents took part in a collaborative study to evaluate experimental procedures to be used in selecting the new standard reference rabies vaccine prepared in human diploid cell cultures. The following procedures were used : (a) the NIH potency test in mice, (b) the antibody binding technique (by either mouse inoculation or the tissue culture method), (c) virus-neutralizing antibody levels in mice used for the NIH test, and (d) antibody induction in human volunteers treated with vaccine alone and in combination with human rabies gamma globulin. The four methods used for determination of rabies antibodies were mouse inoculation, rapid fluorescent focus inhibition, plaque reduction and complement fixation techniques. All results were expressed in International Units as compared to the standard WHO serum and vaccine preparations. In general, a close correlation was noted in results from different laboratories, and it was recommended that the future rabies standard vaccine should be evaluated by three testing procedures, the NIH test, the antibody-binding technique, and antibody levels in mice used for the NIH test.